Author

K. J. Dawson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:clustering· 2 Organism:human· 2 Approach:statistical model· 2 Assay:whole-genome sequencing· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

P. J. Campbell· 2 shared A. Fullam· 1 shared A. L. Godfrey· 1 shared A. Menzies· 1 shared A. R. Green· 1 shared B. Rodriguez-Martin· 1 shared D. C. Wedge· 1 shared D. Glodzik· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

P. J. Campbell

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Phylogenetic reconstruction of myeloproliferative neoplasm reveals very early origins and lifelong evolution

N. Williams, J. Lee, L. Moore, E. J. Baxter, J. Hewinson, K. J. Dawson, A. Menzies, A. L. Godfrey, A. R. Green, P. J. Campbell, J. Nangalia

This study reconstructs the phylogeny of myeloproliferative neoplasms using whole-genome sequencing, revealing early mutation acquisition and lifelong clonal evolution leading to cancer.

bioRxiv · Nov 9, 2020 · PreprintCancer Biology

Genomic landscape and chronological reconstruction of driver events in multiple myeloma

F. Maura, N. Bolli, N. Angelopoulos, K. J. Dawson, D. Leongamornlert, I. Martincorena, T. J. Mitchell, A. Fullam, S. Gonzalez, R. Szalat, B. Rodriguez-Martin, M. K. Samur, D. Glodzik, M. Roncador, M. Fulciniti, , P. J. Campbell

This study reconstructs the genomic evolution of multiple myeloma by analyzing 67 genomes from 30 patients and public datasets, identifying 7 subgroups defined by distinct driver mutations and chronological patterns of genomic events.

bioRxiv · Aug 12, 2018Cancer Biology